These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 18289722)

  • 21. In vitro activity of daptomycin against multidrug-resistant Staphylococcus aureus and S. aureus with known virulence factors, including community-acquired methicillin-resistant isolates.
    Anastasiou DM; Morgan M; Ruane PJ; Steenbergen JN; Katz BD; Alder JD; Thorne GM
    Diagn Microbiol Infect Dis; 2008 Jul; 61(3):339-42. PubMed ID: 18304772
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Community associated MRSA: an alert to paediatricians.
    Jeyaratnam D; Reid C; Kearns A; Klein J
    Arch Dis Child; 2006 Jun; 91(6):511-2. PubMed ID: 16714723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The evolution of Staphylococcus aureus.
    Deurenberg RH; Stobberingh EE
    Infect Genet Evol; 2008 Dec; 8(6):747-63. PubMed ID: 18718557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CA-MRSA lesions: what works, what doesn't.
    McBride D
    J Fam Pract; 2008 Sep; 57(9):588-92. PubMed ID: 18786331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A study of MRSA--a nosocomial pathogen in a tertiary care center in Punjab.
    Oberoi A; Varghese SR
    Indian J Pathol Microbiol; 2006 Apr; 49(2):313-4. PubMed ID: 16933755
    [No Abstract]   [Full Text] [Related]  

  • 26. Useful oldies: oral antibiotics for the treatment of MRSA infections.
    Zvethkova K; Laffeach P; Goldstein FW
    J Hosp Infect; 2004 Aug; 57(4):348-9. PubMed ID: 15262399
    [No Abstract]   [Full Text] [Related]  

  • 27. Community-associated methicillin-resistant Staphylococcus aureus.
    Wallin TR; Hern HG; Frazee BW
    Emerg Med Clin North Am; 2008 May; 26(2):431-55, ix. PubMed ID: 18406982
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Staphylococcus aureus bloodstream infections: risk factors, outcomes, and the influence of methicillin resistance in Calgary, Canada, 2000-2006.
    Laupland KB; Ross T; Gregson DB
    J Infect Dis; 2008 Aug; 198(3):336-43. PubMed ID: 18522502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospital-acquired and community-derived: the future of MRSA?
    Shopsin B; Herring S; Kreiswirth BN
    Clin Infect Dis; 2003 Jul; 37(1):151-2; author reply 152. PubMed ID: 12830425
    [No Abstract]   [Full Text] [Related]  

  • 30. Community acquired methicillin-resistant Staphylococcus aureus hand infections: case reports and clinical implications.
    Karanas YL; Bogdan MA; Chang J
    J Hand Surg Am; 2000 Jul; 25(4):760-3. PubMed ID: 10913220
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of methicillin-resistant Staphylococcus aureus (MRSA) skin infections and MRSA colonization.
    Terushkin V; Brownell I
    J Drugs Dermatol; 2008 Jun; 7(6):597-601. PubMed ID: 18561595
    [No Abstract]   [Full Text] [Related]  

  • 32. Infection control or formulary control: what is the best tool to reduce nosocomial infections due to methicillin-resistant Staphylococcus aureus?
    Hota B
    Clin Infect Dis; 2006 Mar; 42(6):785-7. PubMed ID: 16477554
    [No Abstract]   [Full Text] [Related]  

  • 33. Comparative evaluation of epidemiology and outcomes of methicillin-resistant Staphylococcus aureus (MRSA) USA300 infections causing community- and healthcare-associated infections.
    Moore CL; Hingwe A; Donabedian SM; Perri MB; Davis SL; Haque NZ; Reyes K; Vager D; Zervos MJ
    Int J Antimicrob Agents; 2009 Aug; 34(2):148-55. PubMed ID: 19394801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Perinephric abscess caused by community-acquired methicillin resistant Staphylococcus aureus.
    Malik ZA; Litman N
    Pediatr Infect Dis J; 2007 Aug; 26(8):764. PubMed ID: 17848900
    [No Abstract]   [Full Text] [Related]  

  • 35. [Nosocomial methicillin-resistant staphylococci that remain sensitive to non-beta lactam antibiotics].
    Manfredi R; Nanetti A; Morelli S; Valentini R; Ferri M; Calza L; Chiodo F
    Recenti Prog Med; 2003; 94(7-8):344. PubMed ID: 12868245
    [No Abstract]   [Full Text] [Related]  

  • 36. [MRSA in otorhinolaryngology].
    Simon V
    Laryngorhinootologie; 2007 Oct; 86(10):738-45; quiz 746-7. PubMed ID: 17879903
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic prediction rule for community-associated methicillin-resistant Staphylococcus aureus.
    Popovich K; Hota B; Rice T; Aroutcheva A; Weinstein RA
    J Clin Microbiol; 2007 Jul; 45(7):2293-5. PubMed ID: 17494715
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presumed community-acquired meticillin-resistant Staphylococcus aureus (MRSA) isolates reflect spillover of healthcare-associated MRSA.
    Bygott J; Enoch DA; Carson RP; Karas JA
    J Hosp Infect; 2008 Jun; 69(2):197-8. PubMed ID: 18353492
    [No Abstract]   [Full Text] [Related]  

  • 39. Community-associated methicillin-resistant Staphylococcus aureus: a review.
    Rybak MJ; LaPlante KL
    Pharmacotherapy; 2005 Jan; 25(1):74-85. PubMed ID: 15767223
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Costs of hospital-acquired methicillin-resistant Staphylococcus aureus (MRSA) and its control.
    Gould IM
    Int J Antimicrob Agents; 2006 Nov; 28(5):379-84. PubMed ID: 17045462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.